Celltrion Pharm has ranked among the top searched stocks on 11 days within the past month.

As of 10:32 AM on the 8th, Celltrion Pharm is trading at 126,300 KRW, down 3.22% from the previous day. This marks a 69.3% increase compared to May 11. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.

Today, foreigners are tentatively recorded as net sellers of 9,000 shares. Over the past five days, individual investors have net sold 273,137 shares, while foreigners and institutions have net bought 274,402 shares and 5,212 shares, respectively.

On June 3, Celltrion Pharm became a market issue with news titled "Insulin injection development and consecutive days of COVID-19 treatment experiment results..."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing